Phaos Technology Holdings (Cayman) Limited

POAS · AMEX · Healthcare / Medical Devices

3.29USD+0.28 (+9.30%)

Price History

Full chart

Market Stats

Previous Close3.01

Open3.30

Day Range1.83 – 3.85

52-Week Range0.147 – 7.40

Volume17.73M

Market Cap5.30M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.38

Dividend Yield0.00%

50-Day Avg0.1825

200-Day Avg1.69

About

Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Hong Loon Gan
Employees10
Headquarters55 Ayer Rajah Crescent, Singapore, Singapore, 139949, USA
Websitehttps://phaostech.com

Leadership

Mr. Hook Seng BehExecutive Chairman · b. 1972
Mr. Hong Loon GanInterim CEO, CFO & Executive Director · b. 1985
Prof. Minghui HongChief Technology Advisor

Financials

Income Statement

Currency: SGD	2023-04-30	2024-04-30	2025-04-30	2026-04-30
Total Revenue	650.80K	1.88M	167.71K	132.08K
Growth (%)	-	+189.31%	-91.09%	-21.25%
Cost of Revenue	536.17K	985.10K	130.64K	114.77K
Gross Profit	114.63K	897.70K	37.07K	17.31K
Gross Margin	17.61%	47.68%	22.10%	13.11%
Operating Expense	2.16M	3.40M	5.32M	6.32M
Operating Income	-2.04M	-2.50M	-5.28M	-6.30M
Operating Margin	-313.80%	-132.95%	-3148.28%	-4771.24%
EBITDA	-1.45M	-2.14M	-4.94M	-5.99M
EBITDA Margin	-222.36%	-113.64%	-2946.59%	-4533.54%
Net Income	-1.67M	-2.36M	-5.14M	-6.16M
Net Income Margin	-256.27%	-125.34%	-3063.12%	-4662.26%
R&D	26.96K	90.57K	139.72K	0
R&D as % of Total Revenue	4.14%	4.81%	83.31%	0.00%
Interest Expense	25.07K	43.54K	8.46K	9.17K
Interest Expense % of Total Revenue	3.85%	2.31%	5.05%	6.94%

Balance Sheet

Currency: SGD	2023-04-30	2024-04-30	2025-04-30	2026-04-30
Total Assets	1.38M	5.18M	1.93M	6.68M
Total Liabilities	4.40M	2.26M	3.90M	1.38M
Total Equity	-3.02M	2.92M	-1.96M	5.30M
Cash	54.10K	2.31M	129.55K	762.23K
Total Debt	885.35K	792.58K	265.82K	451.04K
Net Debt	831.26K	-1.52M	136.27K	-311.20K

Cash Flow

Currency: SGD	2023-04-30	2024-04-30	2025-04-30	2026-04-30
Operating Cash Flow	-1.79M	-1.61M	-3.65M	-10.90M
Investing Cash Flow	-187.89K	-1.65M	-332.84K	468.40K
Financing Cash Flow	1.91M	5.52M	1.80M	10.98M
Capital Expenditure	217.64K	121.32K	240.21K	39.72K
Free Cash Flow	-2.01M	-1.73M	-3.89M	-10.94M
FCF to OCF	112.17%	107.54%	106.58%	100.36%

Earnings

Report Date	Sep 18, 2025
EPS Estimate	0.00
EPS Actual	-0.12
Surprise	-
Timing	-

Key Statistics & Ratios

Market Cap5.30M

Enterprise Value2.50M

Trailing P/E0.00

Forward P/E0.00

Price / Sales40.16

Price / Book0.66

EPS-0.38

Book Value0.1319

Revenue (TTM)132.08K

Gross Profit (TTM)17.31K

EBITDA-6.16M

Profit Margin0.00%

Operating Margin-10747.78%

Return on Equity-369.00%

Return on Assets-91.78%

Shares Outstanding16.45M

Shares Float11.52M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Oct 12, 20261:15